BUSINESS5 years ago
Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) Reports Cash And Cash Equivalents Of $70.1 Million In 2019: Zynerba Reports Net Loss Of $10.7 Million in Q4 2019
Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) has reported a net loss of $10.7 million in Q4 2019. Its cash and cash equivalents in 2019 are $70.1 million. According...